Psilocybin Therapy for Depression: A Review of Current Molecular Knowledge
Journal of the Netherlands Society of Toxicology 2024 Marcha Verheijen 1 citation
Depression, affecting over 264 million people globally, presents significant treatment challenges, often due to the limited efficacy and adverse effects of traditional antidepressants and the accessibility issues associated with psychotherapy. Recent advancements in psychedelic-assisted therapy, particularly using psilocybin, a naturally occurring compound found in “magic mushrooms”, shows...
DOI: 10.61833/jnst.2024.0002 (opens in new tab)
Full text (opens in new tab)
Psilocybin
Depression economics
Current fluid
Psychotherapist
+1